Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
2015 · The Lancet Oncology · 245 citations
https://doi.org/10.1016/s1470-2045(15)00414-3
S
Sharmila Pimple
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
2.4K
Citations
21
h-index
32
i10-index
Sharmila Pimple is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cervical Cancer and HPV Research & Global Cancer Incidence and Screening & Hepatitis B Virus Studies. The author has an h-index of 21, co-authored 80 publications.
ORCID: 0000-0003-2976-9107Papers by this author
worksTwo-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study
2019 · Papillomavirus Research · 32 citations
https://doi.org/10.1016/j.pvr.2019.01.004
Case studies on the progress of cervical cancer screening programs in Bhutan, India, and Türkiye
2024 · Vaccine · 1 citations
https://doi.org/10.1016/j.vaccine.2024.03.012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat